Close

Portola Pharma (PTLA) Announces Submission of NDA for Betrixaban for Extended Duration Prophylaxis of VTE

Go back to Portola Pharma (PTLA) Announces Submission of NDA for Betrixaban for Extended Duration Prophylaxis of VTE